CompletedPhase 2NCT00802425

Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss

Studying Sudden sensorineural hearing loss

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Auris Medical AG
Principal Investigator
Markus M Suckfüll, MD
LMU Munich
Intervention
AM-111(drug)
Enrollment
210 target
Eligibility
18-60 years · All sexes
Timeline
20082012

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00802425 on ClinicalTrials.gov

Other trials for Sudden sensorineural hearing loss

Additional recruiting or active studies for the same condition.

See all trials for Sudden sensorineural hearing loss

← Back to all trials